|
1
|
Thayanithy V, Park C, Sarver AL, Kartha
RV, Korpela DM, Graef AJ, Steer CJ, Modiano JF and Subramanian S:
Combinatorial treatment of DNA and chromatin-modifying drugs cause
cell death in human and canine osteosarcoma cell lines. PLoS One.
7:e437202012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guijarro MV, Ghivizzani SC and Gibbs CP:
Animal models in osteosarcoma. Front Oncol. 4:1892014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Federman N, Bernthal N, Eilber FC and Tap
WD: The multidisciplinary management of osteosarcoma. Curr Treat
Options Oncol. 10:82–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jaffe N: Osteosarcoma: Review of the past,
impact on the future. The American experience. Cancer Treat Res.
152:239–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han XR, Sun Y and Bai XZ: The anti-tumor
role and mechanism of integrated and truncated PDCD5 proteins in
osteosarcoma cells. Cell Signal. 24:1713–1721. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rajendran P, Li F, Manu KA, Shanmugam MK,
Loo SY, Kumar AP and Sethi G: γ-tocotrienol is a novel inhibitor of
constitutive and inducible STAT3 signalling pathway in human
hepatocellular carcinoma: Potential role as an antiproliferative,
pro-apoptotic and chemosensitizing agent. Br J Pharmacol.
163:283–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang JS, Chuang LY, Guh JY, Huang YJ and
Hsu MS: Antioxidants attenuate high glucose-induced hypertrophic
growth in renal tubular epithelial cells. Am J Physiol Renal
Physiol. 293:F1072–F1082. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Du W, Hong J, Wang YC, Zhang YJ, Wang P,
Su WY, Lin YW, Lu R, Zou WP, Xiong H, et al: Inhibition of
JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via
mitochondrial pathway. J Cell Mol Med. 16:1878–1888. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niu G, Wright KL, Huang M, Song L, Haura
E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, et al:
Constitutive Stat3 activity up-regulates VEGF expression and tumor
angiogenesis. Oncogene. 21:2000–2008. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie TX, Huang FJ, Aldape KD, Kang SH, Liu
M, Gershenwald JE, Xie K, Sawaya R and Huang S: Activation of stat3
in human melanoma promotes brain metastasis. Cancer Res.
66:3188–3196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nam S, Xie J, Perkins A, Ma Y, Yang F, Wu
J, Wang Y, Xu RZ, Huang W, Horne DA, et al: Novel synthetic
derivatives of the natural product berbamine inhibit Jak2/Stat3
signaling and induce apoptosis of human melanoma cells. Mol Oncol.
6:484–493. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Um HJ, Min KJ, Kim DE and Kwon TK:
Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of
human renal carcinoma Caki cells. Biochem Biophys Res Commun.
427:24–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park JH, Darvin P, Lim EJ, Joung YH, Hong
DY, Park EU, Park SH, Choi SK, Moon ES, Cho BW, et al:
Hwanggeumchal sorghum induces cell cycle arrest, and suppresses
tumor growth and metastasis through Jak2/STAT pathways in breast
cancer xenografts. PLoS One. 7:e405312012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park WH: MAPK inhibitors differentially
affect gallic acid-induced human pulmonary fibroblast cell growth
inhibition. Mol Med Rep. 4:193–204. 2011.PubMed/NCBI
|
|
17
|
You BR and Park WH: The effects of
mitogen-activated protein kinase inhibitors or small interfering
RNAs on gallic acid induced HeLa cell death in relation to reactive
oxygen species and glutathione. J Agric Food Chem. 59:763–771.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen YC, Chang CN, Hsu HC, Chiou SJ, Lee
LT and Hseu TH: Sennoside B inhibits PDGF receptor signaling and
cell proliferation induced by PDGF-BB in human osteosarcoma cells.
Life Sci. 84:915–922. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Noh K, Kim KO, Patel NR, Staples JR,
Minematsu H, Nair K and Lee FY: Targeting inflammatory kinase as an
adjuvant treatment for osteosarcomas. J Bone Joint Surg Am.
93:723–732. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pezzuto JM: Plant-derived anticancer
agents. Biochem Pharmacol. 53:121–133. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ahmad A, Sakr WA and Rahman KM: Novel
targets for detection of cancer and their modulation by
chemopreventive natural compounds. Front Biosci (Elite Ed).
4:410–425. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hijová E, Szabadosova V, Štofilová J and
Hrčková G: Chemopreventive and metabolic effects of inulin in colon
cancer development. J Vet Sci. 14:387–393. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Park EJ and Pezzuto JM: Antioxidant marine
products in cancer chemoprevention. Antioxid Redox Signal.
19:115–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen JC, Chiu MH, Nie RL, Cordell GA and
Qiu SX: Cucurbitacins and cucurbitane glycosides: Structures and
biological activities. Nat Prod Rep. 22:386–399. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Geissman TA: New substances of plant
origin. Annu Rev Pharmacolog. 4:305–316. 1964. View Article : Google Scholar
|
|
27
|
Farias MR, Schenkel EP, Mayer R and Rücker
G: Cucurbitacins as constituents of Wilbrandia ebracteata. Planta
Med. 59:272–275. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peters RR, Farias MR and Ribeiro-do-Valle
RM: Anti-inflammatory and analgesic effects of cucurbitacins from
Wilbrandia ebracteata. Planta Med. 63:525–528. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Blaskovich MA, Sun J, Cantor A, Turkson J,
Jove R and Sebti SM: Discovery of JSI-124 (cucurbitacin I), a
selective Janus kinase/signal transducer and activator of
transcription 3 signaling pathway inhibitor with potent antitumor
activity against human and murine cancer cells in mice. Cancer Res.
63:1270–1279. 2003.PubMed/NCBI
|
|
30
|
Shi X, Franko B, Frantz C, Amin HM and Lai
R: JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal
transducer and activator of transcription-3 signalling,
downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and
induces apoptosis in ALK-positive anaplastic large cell lymphoma
cells. Br J Haematol. 135:26–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tannin-Spitz T, Grossman S, Dovrat S,
Gottlieb HE and Bergman M: Growth inhibitory activity of
cucurbitacin glucosides isolated from Citrullus colocynthis on
human breast cancer cells. Biochem Pharmacol. 73:56–67. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yin D, Wakimoto N, Xing H, Lu D, Huynh T,
Wang X, Black KL and Koeffler HP: Cucurbitacin B markedly inhibits
growth and rapidly affects the cytoskeleton in glioblastoma
multiforme. Int J Cancer. 123:1364–1375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ho YT, Yang JS, Li TC, Lin JJ, Lin JG, Lai
KC, Ma CY, Wood WG and Chung JG: Berberine suppresses in vitro
migration and invasion of human SCC-4 tongue squamous cancer cells
through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and
-9. Cancer Lett. 279:155–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mizoguchi H, Nakade J, Tachibana M, Ibi D,
Someya E, Koike H, Kamei H, Nabeshima T, Itohara S, Takuma K, et
al: Matrix metalloproteinase-9 contributes to kindled seizure
development in pentylenetetrazole-treated mice by converting
pro-BDNF to mature BDNF in the hippocampus. J Neurosci.
31:12963–12971. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Güllü IH, Kurdoğlu M and Akalin I: The
relation of gelatinase (MMP-2 and -9) expression with distant site
metastasis and tumour aggressiveness in colorectal cancer. Br J
Cancer. 82:2492000.PubMed/NCBI
|
|
37
|
Kilian M, Gregor JI, Heukamp I, Hanel M,
Ahlgrimm M, Schimke I, Kristiansen G, Ommer A, Walz MK, Jacobi CA
and Wenger FA: Matrix metalloproteinase inhibitor RO 28–2653
decreases liver metastasis by reduction of MMP-2 and MMP-9
concentration in BOP-induced ductal pancreatic cancer in Syrian
Hamsters: Inhibition of matrix metalloproteinases in pancreatic
cancer. Prostaglandins Leukot Essent Fatty Acids. 75:429–434. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mizutani K, Kofuji K and Shirouzu K: The
significance of MMP-1 and MMP-2 in peritoneal disseminated
metastasis of gastric cancer. Surg Today. 30:614–621. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qazi A, Pal J, Maitah M, Fulciniti M,
Pelluru D, Nanjappa P, Lee S, Batchu RB, Prasad M, Bryant CS, et
al: Anticancer activity of a broccoli derivative, sulforaphane, in
barrett adenocarcinoma: Potential use in chemoprevention and as
adjuvant in chemotherapy. Transl Oncol. 3:389–399. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hartojo W, Silvers AL, Thomas DG, Seder
CW, Lin L, Rao H, Wang Z, Greenson JK, Giordano TJ, Orringer MB, et
al: Curcumin promotes apoptosis, increases chemosensitivity, and
inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl
Oncol. 3:99–108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Monian P and Jiang X: Clearing the final
hurdles to mitochondrial apoptosis: Regulation post cytochrome C
release. Exp Oncol. 34:185–191. 2012.PubMed/NCBI
|
|
43
|
Soriano ME and Scorrano L: The interplay
between BCL-2 family proteins and mitochondrial morphology in the
regulation of apoptosis. Adv Exp Med Biol. 687:97–114. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kiu H and Nicholson SE: Biology and
significance of the JAK/STAT signalling pathways. Growth Factors.
30:88–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chau MN and Banerjee PP: Development of a
STAT3 reporter prostate cancer cell line for high throughput
screening of STAT3 activators and inhibitors. Biochem Biophys Res
Commun. 377:627–631. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yue P and Turkson J: Targeting STAT3 in
cancer: How successful are we? Expert Opin Investig Drugs.
18:45–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chambliss OL and Jone CM: Cucurbitacins:
Specific insect attractants in Cucurbitaceae. Science.
153:1392–1393. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yesilada E, Tanaka S, Sezik E and Tabata
M: Isolation of an anti-inflammatory principle from the fruit juice
of Ecballium elaterium. J Nat Prod. 51:504–508. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang M, Zhang H, Sun C, Shan X, Yang X,
Li-Ling J and Deng Y: Target constitutive activation of signal
transducer and activator of transcription 3 in human hepatocellular
carcinoma cells by cucurbitacin B. Cancer Chemother Pharmacol.
63:635–642. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wakimoto N, Yin D, O'Kelly J, Haritunians
T, Karlan B, Said J, Xing H and Koeffler HP: Cucurbitacin B has a
potent antiproliferative effect on breast cancer cells in vitro and
in vivo. Cancer Sci. 99:1793–1797. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li Y, Li W, Chen X, Jiang H, Sun J, Chen H
and Lv S: Integrated analysis identifies interaction patterns
between small molecules and pathways. Biomed Res Int.
2014:9318252014.PubMed/NCBI
|
|
52
|
Wen D, Danquah M, Chaudhary AK and Mahato
RI: Small molecules targeting MicroRNA for cancer therapy: Promises
and obstacles. J Control Release. 219:237–247. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wondrak GT, Villeneuve NF, Lamore SD,
Bause AS, Jiang T and Zhang DD: The cinnamon-derived dietary factor
cinnamic aldehyde activates the Nrf2-dependent antioxidant response
in human epithelial colon cells. Molecules. 15:3338–3355. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liang CZ, Zhang X, Li H, Tao YQ, Tao LJ,
Yang ZR, Zhou XP, Shi ZL and Tao HM: Gallic acid induces the
apoptosis of human osteosarcoma cells in vitro and in vivo via the
regulation of mitogen-activated protein kinase pathways. Cancer
Biother Radiopharm. 27:701–710. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liu Z, Li D, Zhao W, Zheng X, Wang J and
Wang E: A potent lead induces apoptosis in pancreatic cancer cells.
PLoS One. 7:e378412012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gross A, McDonnell JM and Korsmeyer SJ:
Bcl-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Reed JC: Apoptosis-regulating proteins as
targets for drug discovery. Trends Mol Med. 7:314–319. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang SH, Chien CM, Lu MC, Lin YH, Hu XW
and Lin SR: Upregulation of Bax and endonuclease G, and
down-modulation of Bcl-XL involved in cardiotoxin III-induced
apoptosis in K562 cells. Exp Mol Med. 38:435–444. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Coussens LM and Werb Z: Matrix
metalloproteinases and the development of cancer. Chem Biol.
3:895–904. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang L, Shi J, Feng J, Klocker H, Lee C
and Zhang J: Type IV collagenase (matrix metalloproteinase-2 and
-9) in prostate cancer. Prostate Cancer Prostatic Dis. 7:327–332.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
O'Shea JJ, Gadina M and Schreiber RD:
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway.
Cell. 109 Suppl:121–131. 2002. View Article : Google Scholar
|
|
62
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: A leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yu H and Jove R: The STATs of cancer-new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Epling-Burnette PK, Liu JH,
Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang
JM, Yang-Yen HF, Karras J, et al: Inhibition of STAT3 signaling
leads to apoptosis of leukemic large granular lymphocytes and
decreased Mcl-1 expression. J Clin Invest. 107:351–362. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Liu T, Zhang M, Zhang H, Sun C and Deng Y:
Inhibitory effects of cucurbitacin B on laryngeal squamous cell
carcinoma. Eur Arch Otorhinolaryngol. 265:1225–1232. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kim BM and Chung HW: Desferrioxamine (DFX)
induces apoptosis through the p38-caspase8-Bid-Bax pathway in PHA
stimulated human lymphocytes. Toxicol Appl Pharmacol. 228:24–31.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Mendes O, Kim HT, Lungu G and Stoica G:
MMP2 role in breast cancer brain metastasis development and its
regulation by TIMP2 and ERK1/2. Clin Exp Metastasis. 24:341–351.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Peng L, Xing X, Li W, Qu L, Meng L, Lian
S, Jiang B, Wu J and Shou C: PRL-3 promotes the motility, invasion,
and metastasis of LoVo colon cancer cells through PRL-3-integrin
beta1-ERK1/2 and-MMP2 signaling. Mol Cancer. 8:1102009. View Article : Google Scholar : PubMed/NCBI
|
